Buffer transport in peritoneal dialysis

Slides:



Advertisements
Similar presentations
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Advertisements

Acid-base profile in patients on PD
Volume 59, Issue 4, Pages (April 2001)
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
A.M. Thompson, T.G. Pickering  Kidney International 
Volume 64, Issue 4, Pages (October 2003)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Plasma sodium and hypertension
Linear and logistic regression analysis
Acid-base profile in patients on PD
Volume 84, Issue 5, Pages (November 2013)
End-stage renal disease in developing countries
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Use of icodextrin in high transport ultrafiltration failure
D. Teta, M. Maillard, G. Halabi, M. Burnier  Kidney International 
Impact of new dialysis solutions on peritonitis rates
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Volume 73, Pages S131-S136 (April 2008)
Volume 53, Issue 4, Pages (April 1998)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Glucose sparing in peritoneal dialysis: Implications and metrics
Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais 
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury  D.P. Gabriel, J.T. Caramori,
George A. Kaysen, Burl R. Don
Volume 64, Issue 4, Pages (October 2003)
S.G. John, N.M. Selby, C.W. McIntyre  Kidney International 
Volume 73, Pages S5-S17 (April 2008)
Pharmacokinetics of icodextrin in peritoneal dialysis patients
Volume 73, Pages S94-S101 (April 2008)
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions  P.M. ter Wee, R.H.J. Beelen, J.
Peritoneal dialysis adequacy and risk of death
Volume 76, Issue 6, Pages (September 2009)
Volume 68, Issue 2, Pages (August 2005)
Clifford J. Holmes, Dirk Faict  Kidney International 
Microbiology and outcomes of peritonitis in North America
Nephrology Crossword: Peritoneal Dialysis
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Future of icodextrin as an osmotic agent in peritoneal dialysis
Randomized long-term evaluation of bicarbonate-buffered CAPD solution
The role of daily dialysis in the control of hyperphosphatemia
Volume 55, Issue 4, Pages (April 1999)
Profiling of peritoneal ultrafiltration
Volume 56, Issue 5, Pages (November 1999)
Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson  Kidney International 
Volume 73, Pages S72-S75 (April 2008)
Volume 64, Pages S84-S93 (December 2003)
Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction  Adam G. McLean, Andrew Davenport, Dominic.
Urea and nitrogen excretion in pediatric peritoneal dialysis patients
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Phosphate binders on iron basis: A new perspective?
Volume 70, Pages S84-S90 (November 2006)
Role of sodium in hemodialysis
Volume 59, Issue 4, Pages (April 2001)
Volume 56, Pages S37-S40 (November 1999)
Charles A. Herzog  Kidney International 
Quantification of free water transport in peritoneal dialysis
Review of clinical trial experience with icodextrin
Volume 65, Issue 1, Pages (January 2004)
Strategies for iron supplementation: Oral versus intravenous
The International Pediatric Peritonitis Registry: Starting to walk
Development and differentiation of endothelium
Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. Gentamicin plasma and peritoneal dialysate.
Metabolic and laboratory effects of icodextrin
Presentation transcript:

Buffer transport in peritoneal dialysis Olof Heimburger, Salim Mujais  Kidney International  Volume 64, Pages S37-S42 (December 2003) DOI: 10.1046/j.1523-1755.2003.08804.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Schematic representation of the metabolism of lactate, pyruvate, and acetate in liver periportal cells. G6P, glucose-6-phosphate. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Temporal profile of dialysate bicarbonate with two dialysis solutions: traditional lactate solution (♦) and a solution with a mixed-buffer preparation (bicarbonate/lactate) (gray squares). The study was performed in seven subjects who received both preparations in random order. Data from Heimburger et al: Peritoneal transport with lactate 40mmol/L (L) vs. bicarbonate/lactate 25/15mmol/L (BL) dialysis fluids. J Am Soc Nephrol 9:192A, 1998. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Correlation between blood bicarbonate level and end-of-dwell dialysate bicarbonate concentration with the use of lactate-based dialysis solution. Data from Heimburger et al: Peritoneal transport with lactate 40mmol/L (L) vs. bicarbonate/lactate 25/15mmol/L (BL) dialysis fluids. J Am Soc Nephrol 9:192A, 1998. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Temporal profile of dialysate pCO2 with two dialysis solutions: traditional lactate solution (♦) and a solution with a mixed-buffer preparation (bicarbonate/lactate) (gray squares). The study was performed in seven subjects who received both preparations in random order. Data from Heimburger et al: Peritoneal transport with lactate 40mmol/L (L) vs. bicarbonate/lactate 25/15mmol/L (BL) dialysis fluids. J Am Soc Nephrol 9:192A, 1998. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Temporal profile of dialysate pH with two dialysis solutions: traditional lactate solution (♦) and a solution with a mixed-buffer preparation (bicarbonate/lactate) (gray squares). The study was performed in seven subjects who received both preparations in random order. Data from Heimburger et al: Peritoneal transport with lactate 40mmol/L (L) vs. bicarbonate/lactate 25/15mmol/L (BL) dialysis fluids. J Am Soc Nephrol 9:192A, 1998. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 Temporal profile of dialysate bicarbonate and lactate with traditional lactate solution. Redrawn from reference [9]. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 7 Daily balance of alkali (lactate gain and bicarbonate loss) during continuous ambulatory peritoneal dialysis (CAPD) treatment with traditional lactate solution. Panel (A) from reference [11], panel (B) from reference [8]. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 8 Effect of an increase in total alkali content in lactate-based solutions on plasma bicarbonate in patients on continuous ambulatory peritoneal dialysis (CAPD). Black circles indicate solutions of 35mmol/L lactate; gray squares indicate solutions of 40mmol/L lactate. Redrawn from reference [14]. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 9 Profile of the levels of pCO2 prevailing in dialysis solutions of different concentrations of bicarbonate at various pH levels. The values for solutions with complementary bicarbonate/lactate buffer with bicarbonate concentration of 25 are indicated in the gray circle. The open circle encompasses the values for pure bicarbonate solutions of various concentrations. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 10 Overall profile of the changes in dialysate composition during a standard continuous ambulatory peritoneal dialysis (CAPD) dwell with traditional lactate solution. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 11 Overall profile of the changes in dialysate composition during a standard continuous ambulatory peritoneal dialysis (CAPD) dwell with bicarbonate/lactate solution. Kidney International 2003 64, S37-S42DOI: (10.1046/j.1523-1755.2003.08804.x) Copyright © 2003 International Society of Nephrology Terms and Conditions